Skip to search formSkip to main contentSkip to account menu

GLPG0187

Known as: Integrin Receptor Antagonist GLPG0187 
A small molecule integrin receptor antagonist (IRA) with potential antineoplastic activity. Upon administration, GLPG0187 binds to and blocks the… 
National Institutes of Health

Related topics

Related topics

8 relations
Angiogenesis InhibitionCell Adhesion InhibitionIntegrin InhibitionIntegrin alphaVbeta3

Broader (2)

NaphthyridinesSulfonamides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Prostate cancer cells home to bone using a novel in vivo model : modulation by the integrin antagonist GLPG 0187 Running title : new in vivo model for tracking early prostate cancer homing to bone
Urology Research Laboratory 3 , Department of Urology, University of Bern, Murtenstrasse 35, CH3010, Bern, Switzerland Department… 
2011
2011
PP 87 Molecular imaging demonstrates GLPG0187, a small-molecule integrin antagonist, binds to RGD-integrin receptors in vivo and is efficacious in tumor and metastasis models
2010
2010
Abstract 1568: GLPG0187, a small molecule integrin antagonist, shows good safety and decrease in CTX levels in single ascending dose study
Introduction : GLPG0187, a small molecule integrin antagonist with nanomolar affinity for the RGD-integrin receptors αvβ1, αvβ3… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)